Skip to main content

Branded

  • AP: Generic drug competition amendment approved as part of Food and Drug Act

    WASHINGTON — An amendment to improve generic drug competition has been approved as part of the Food and Drug Reauthorization Act, U.S. Sen. Susan Collins (R-Maine) told The Associated Press.

    Collins said the amendment was approved May 11 at a Senate Health, Education, Labor and Pensions Committee business meeting, adding the measure is part of an investigation into "aggressive price hikes" in prescription drugs, and it will improve generic drug competition to help make prices lower.

  • NCPA reaches out to Senate Republicans regarding AHCA

    ALEXANDRIA, Va. – The National Community Pharmacists Association on Thursday urged Senate Republicans to keep a number of important prescription drug-related provisions as they consider House passage of H.R. 1628, the American Health Care Act.

    “Prescription drug coverage is an essential health benefit,” stated Douglas Hoey, CEO NCPA. “Any meaningful drug coverage should include patient choice of pharmacy and access to face-to-face counseling with a community pharmacist they know and trust.”

  • Scott Gottlieb confirmed as FDA commissioner

    WASHINGTON — By a vote of 57 to 42 (with one Senator not voting), the Senate on Tuesday confirmed the nomination of Scott Gottlieb, of Connecticut, to be commissioner of the Food and Drug Administration, Department of Health and Human Services

  • FDA approves Pfizer bladder cancer drug

    WASHINGTON — EMD Serono, the biopharmaceutical business of Merck KGaA and Pfizer announced that the Food and Drug Administration has approved Bavencio (avelumab) Injection for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, or who have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.

  • Maine Gov. LePage: People on opioids have ‘advantage’ over allergy sufferers

    AUGUSTA, Maine — Maine Gov. Paul LePage said during a radio call-in show that people on opioids have an “advantage” of receiving free Narcan shots versus those who have allergies and have to pay for their medications.

    According to The Associated Press, LePage specifically referred to a letter he received from a dad whose family members have to carry allergy pens for reactions to peanuts and bee stings.

    People with allergies have "done nothing" but have to pay for it, the governor said during the radio show.

  • Express Scripts launches discount drug service

    ST. LOUIS — Express Scripts on Monday launched Inside Rx, a new, partially owned subsidiary that applies Express Scripts' purchasing power to expand affordable access to brand and generic medications for patients in need. According to Express Scripts, Inside Rx has partnered with GoodRx to deliver average savings of 34% on prescription medications for the uninsured and those who experience high out-of-pocket costs for their prescription medications.

  • FDA approves Novartis breast cancer treatment

    EAST HANOVER, N.J. — Novartis announced that the Food and Drug Administration has approved the Kisqali Femara Co-Pack (ribociclib tablets; letrozole tablets) for the treatment of hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer in postmenopausal women. According to Novartis, the Kisqali Femara Co-Pack is the first, and only currently available, combination pack with two prescription products in advanced breast cancer.

  • CNBC: Drug pricing not discussed in White House biomedical meeting

    WASHINGTON — Executives from Celgene, Regeneron and Vertex represented the drug industry Monday during a biomedical research discussion, but drug prices, long a concern of President Donald Trump, was not discussed during the two-hour meeting, reported CNBC.

    "There's all kinds of elephants, and the room is crowded with them I suppose, but that one didn't get much attention," Dr. Francis Collins, director of the National Institutes of Health, told CNBC in an interview directly after the meeting.

X
This ad will auto-close in 10 seconds